Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

GE28-9642-86

TempliPhi - 2000 Reaction Kit

Cytiva 28-9642-86

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41116006
NACRES:
NA.85

manufacturer/tradename

Cytiva 28-9642-86

shipped in

dry ice

storage temp.

−70°C

General description

TempliPhi Kits use a unique process to efficiently prepare micrograms of circular DNA from picogram input material. The DNA templates are prepared by rolling circle amplification (RCA) using bacteriophage Phi29 DNA polymerase. TempliPhi uses an isothermal method for the exponential amplification of circular DNA. Phi29 DNA polymerase is active at 30° C, enabling amplification to be performed at this temperature without the need for thermal cycling. The TempliPhi protocol requires less than 20 min of hands-on time to amplify 96 samples from bacterial colonies.

Two different types of TempliPhi DNA Amplification Kits are available to meet different throughput requirements. illustra TempliPhi DNA Amplification Kit for 2000 reactions contains premixed components and generates templates after overnight incubation. The 100- and 500-reaction kits contain separate, unmixed components for enhanced stability.

The illustra TempliPhi DNA Sequencing Template Amplification Kit has a distinct protocol and workflow compared to the 100/500 reaction size. Procedures for each kit are not interchangeable. Prior optimization is needed.

Application

High-throughput preparation of circular DNA templates for cycle sequencing, cloning, and transformation.

Features and Benefits

  • Prepare circular DNA templates for cycle sequencing, cloning, and transformation in 4 to 6 h.
  • Generate microgram quantities of template DNA from picogram amounts of starting material.
  • Use amplified DNA directly for cycle sequencing without purification.
  • Amplify DNA from bacterial or M13 liquid cultures, colonies, plaques, glycerol stocks, or purified circular (plasmid or M13) DNA.
  • Simple protocol reduces time, labor, and consumables needed for template preparation, and workflow enables easy automation.

Storage and Stability

Please be aware this product may be shipped 30 days before the expiration date. For more information on the batch specific expiration date, please contact technical service.
S-re Denature buffer and control DNA at -70°C or -15°C - -30°C. S-re TempliPhi premix at -70°C. Do not s-re TempliPhi premix at -15°C - -30°C. Thaw the premix on ice and maintain at 0–4°C during handling. Do not allow premix - warm above 4°C prior - amplification

Analysis Note

To view the Certificate of Analysis for this product, please visit www.cytiva.com.

Legal Information

TempliPhi
On packaging and insert for kits:
For use only as licensed by Qiagen GmbH. and Cytiva. The Phi 29 DNA polymerase may not be re-sold or used except in conjunction with the other components of this kit. See US patent numbers 5,854,033, 6,124,120, 6,143,495, 6,323,009, 5,198,543, 5,576,204, and their equivalents in other countries.
On container:
Subject to proprietary rights of Cytiva. May not be re-sold or used except with the other components of this kit. See US patent numbers 5,576,204, and their equivalents in other countries.
TempliPhi is a trademark of Cytiva
illustra is a trademark of Cytiva

related product

Storage Class Code

12 - Non Combustible Liquids


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Michael J Reagin et al.
Journal of biomolecular techniques : JBT, 14(2), 143-148 (2003-12-17)
Preparing plasmid templates for DNA sequencing is the most time-consuming step in the sequencing process. Current template preparation methods rely on a labor-intensive, multistep procedure that takes up to 24 h and produces templates of varying quality and quantity. The
Tracy L Meiring et al.
Virology journal, 9, 164-164 (2012-08-18)
Human papillomavirus (HPV) is the aetiological agent for cervical cancer and genital warts. Concurrent HPV and HIV infection in the South African population is high. HIV positive (+) women are often infected with multiple, rare and undetermined HPV types. Data

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service